TY - JOUR
T1 - ATP-dependent allosteric DNA enzymes
AU - Levy, Matthew
AU - Ellington, Andrew D.
N1 - Funding Information:
We thank Kenneth A. Johnson for a discussion on allostery. This work was supported by grant NCC2-1055 from the National Aeronautics and Space Administration (NASA) Astrobiology Institute, a research grant from the Arnold and Mabel Beckman Foundation, and National Institutes of Health grant 1R01GM61789-01A1.
PY - 2002
Y1 - 2002
N2 - Effector-activated ribozymes that respond to small organic molecules have previously been generated by appending binding species (aptamers) to ribozymes. In order to determine if deoxyribozymes can similarly be activated by effector molecules, we have appended an anti-adenosine aptamer to a selected deoxyribozyme ligase. The resultant constructs are specifically activated by ATP. Optimization of the joining region resulted in ligases that are activated up to 460-fold by ATP. The selected deoxyribozyme catalyzes ligation largely via a templating mechanism. Effector activation is surprisingly achieved by suppression of the rate of the background, templated ligation reaction in the absence of the effector molecule, probably by misalignment of the oligonucleotide substrates. This novel allosteric mechanism has not previously been observed for nucleic-acid catalysts and is rare even in protein catalysts.
AB - Effector-activated ribozymes that respond to small organic molecules have previously been generated by appending binding species (aptamers) to ribozymes. In order to determine if deoxyribozymes can similarly be activated by effector molecules, we have appended an anti-adenosine aptamer to a selected deoxyribozyme ligase. The resultant constructs are specifically activated by ATP. Optimization of the joining region resulted in ligases that are activated up to 460-fold by ATP. The selected deoxyribozyme catalyzes ligation largely via a templating mechanism. Effector activation is surprisingly achieved by suppression of the rate of the background, templated ligation reaction in the absence of the effector molecule, probably by misalignment of the oligonucleotide substrates. This novel allosteric mechanism has not previously been observed for nucleic-acid catalysts and is rare even in protein catalysts.
UR - http://www.scopus.com/inward/record.url?scp=0036236786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036236786&partnerID=8YFLogxK
U2 - 10.1016/S1074-5521(02)00123-0
DO - 10.1016/S1074-5521(02)00123-0
M3 - Article
C2 - 11983331
AN - SCOPUS:0036236786
SN - 2451-9448
VL - 9
SP - 417
EP - 426
JO - Cell Chemical Biology
JF - Cell Chemical Biology
IS - 4
ER -